May 2026
The global Parkinsons disease biomarkers market size was evaluated at USD 1.35 billion in 2025 and is predicted to hit around USD 4.88 billion by 2035, growing at a CAGR of 13.80%.
September 2025
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
July 2025
The global in-vitro inflammatory bowel disease diagnostics market size was valued at USD 1.74 billion in 2024 and is expected to hit around USD 3.02 billion by 2034, at a CAGR of 5.64%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
June 2026
The global Huntingtons disease market size was evaluated at USD 1.42 billion in 2025 and is predicted to hit around USD 6.48 billion by 2035, growing at a CAGR of 17.20%.
June 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 3.75 billion in 2025 with a CAGR of 15.48%.
May 2026
The global biomarkers market size was valued at USD 94.24 billion in 2025 and is expected to hit around USD 355.72 billion by 2035 with a CAGR of 14.21%.
May 2026
The infectious respiratory disease diagnostics market size is projected to hit around USD 96.57 billion by 2035 from USD 57.55 billion in 2025 with a CAGR of 5.31%.
May 2026
The global disease management apps market size is calculated at USD 10.20 billion in 2025 and is projected to hit around USD 27 billion by 2035 with a CAGR of 10.22%.
May 2026
The global CNS biomarkers market size was evaluated at USD 7.80 billion in 2025 and is predicted to hit around USD 26.13 billion by 2035, growing at a CAGR of 12.90%.
May 2026
The global diabetic kidney disease market size was valued at USD 3.25 billion in 2025 and is projected to hit around USD 5.23 billion by 2035 with a CAGR of 4.87%.
May 2026
The neurological biomarkers market size reached USD 10.32 billion in 2025 and is projected to surpass around 34.02 billion by 2035, with a solid CAGR of 12.67%.
May 2026
The global graves disease (overactive thyroid) market size is estimated to hit around USD 3.69 billion by 2035 increasing from USD 2.26 billion in 2025, with a CAGR of 5.02%.
May 2026
The global Alzheimers disease diagnostics market size was evaluated at USD 9.40 billion in 2025 and is predicted to hit around USD 26.21 billion by 2035, growing at a CAGR of 10.80%.
April 2026
The global inflammatory bowel disease treatment market size is projected to hit around USD 32.46 billion by 2035 from USD 22.38 billion in 2025, with a CAGR of 3.79%.
April 2026
The global inflammatory disease market size was evaluated at USD 125.00 billion in 2025 and is predicted to hit around USD 241.34 billion by 2035, growing at a CAGR of 6.80%.
April 2026
The global enteric disease testing market size was evaluated at USD 4.30 billion in 2025 and is predicted to hit around USD 8.09 billion by 2035, growing at a CAGR of 6.52%.
March 2026
The global periodontal disease treatment market size was evaluated at USD 2.94 billion in 2025 and is predicted to hit around USD 6.23 billion by 2035, growing at a CAGR of 7.80%.
March 2026
The global infectious disease immunoassay market size was evaluated at USD 2.88 billion in 2025 and is predicted to hit around USD 8.87 billion by 2035, growing at a CAGR of 11.90%.
March 2026
The global infectious disease diagnostics market size is expected to reach around USD 71.06 billion by 2035 from USD 35.39 billion in 2025 with a CAGR of 7.22%.
February 2026
The global veterinary biomarkers market size is estimated to hit around USD 4.13 billion by 2035 increasing from USD 1.24 billion in 2025, with a CAGR of 12.79%.
February 2026
The global foot and mouth disease vaccine market size is expected to reach around USD 3.48 billion by 2035 from USD 1.94 billion in 2025 with a CAGR of 6.02%.
February 2026
The global respiratory disease vaccine market size was calculated at USD 101.10 billion in 2025 and is projected to hit around USD 123.77 billion by 2035 with a CAGR of 2.04%.
January 2026
The global fabry disease treatment market size reached USD 2.45 billion in 2025 and is estimated to hit around USD 5.20 billion by 2035 with a CAGR of 7.82%.
January 2026
The global parkinsons disease therapeutics market size is estimated at USD 7.02 billion in 2025 and is projected to hit around USD 14.28 billion by 2035 with a CAGR of 7.36%.
January 2026
The global digital biomarkers market size calculated at USD 5.04 billion in 2025 and is projected to hit around USD 36.98 billion by 2035 with a CAGR of 22.05%.
January 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.10 billion in 2025 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
January 2026
The global cancer biomarkers market size was estimated at USD 15.58 billion in 2025 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
January 2026
The global end stage renal disease market size was estimated at USD 153.72 billion in 2025 and is predicted to hit around USD 531.76 billion by 2035 with a CAGR of 13.21%.
January 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com